Table 4.
CMR findings between patients with no septal LGE and those with septal LGE involvement
| Patient groups | No septal involvement (n = 96) | Septal involvement (n = 17) | P-value |
|---|---|---|---|
| Age (years) |
14.6 ± 4.9* |
18.3 ± 5.5 |
0.006 |
| Heart rate (bmp) |
97.5 ± 16.7 |
97.3 ± 7.9 |
0.97 |
| BSA (m2) |
1.4 ± 0.32 |
1.5 ± 0.29 |
0.22 |
| LVEF (%) |
59.5 ± 8.3* |
42.6 ±16.9 |
<0.0001 |
| LVEDV/BSA (mL/m2) |
72.7 ± 17.1* |
111.2 ±44.1 |
<0.0001 |
| LVM/BSA |
51.3 ± 12.7* |
61.1 ± 15.2 |
0.006 |
| NPS with LGE |
4.2 ± 2.2* |
9.4 ± 3.1 |
<0.0001 |
| Age < 10 years (n = 14) |
-------------- |
7.1% (95% CI, 0.18-33.9) |
0.001 |
| Age 10 – 15 years (n = 51) |
-------------- |
7.8% (95% CI, 2.2-18.9) |
<0.0001 |
| Age > 15 years ( n = 48) | -------------- | 25.0% (95% CI, 13.6-39.6) | 0.0005 |
Abbreviations: BSA Body Surface Area, BMP Beats per minute, CI Confidence Interval, CMR Cardiovascular Magnetic Resonance, LGE Late Gadolinium Enhancement, LVEF Left Ventricular Ejection Fraction, LVEDV Left Ventricular End-Diastolic Volume, LVM Left Ventricular Mass, mL Milliliter, m2 Meter Square, n Number of patients, NPS Number of Positive Segments, * = P value (<0.05) is significant.